Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$933K Buy
15,432
+312
+2% +$18.3K 0.4% 70
2015
Q3
$851K Buy
15,120
+9,530
+170% +$511K 0.39% 66
2015
Q2
$283K Sell
5,590
-3,933
-41% -$208K 0.11% 99
2015
Q1
$524K Sell
9,523
-48,713
-84% -$2.86M 0.21% 86
2014
Q4
$3.52M Buy
58,236
+135
+0.2% +$7.47K 1.45% 29
2014
Q3
$2.88M Sell
58,101
-640
-1% -$32.8K 1.16% 37
2014
Q2
$3.16M Sell
58,741
-640
-1% -$33.2K 1.26% 33
2014
Q1
$3.05M Sell
59,381
-887
-1% -$42.7K 1.28% 34
2013
Q4
$2.83M Buy
60,268
+1,446
+2% +$67.6K 1.11% 44
2013
Q3
$2.71M Buy
+58,822
New +$2.9M 1.14% 45

Other funds holding SCG

Aspiriant Holdings S3's SCG Position: Q4 2015 in Review

Aspiriant Holdings S3 increased its Scana (SCG) stake by 2.1% in Q4 2015, buying an estimated $18.3K and bringing the position to 15,432 shares worth $933K. The position accounts for 0.4% of the portfolio, ranked #70.

Aspiriant Holdings S3 first reported a position in SCG in Q3 2013 and has held it in 10 quarters since. The position peaked at $3.52M in Q4 2014. 458 funds tracked by Wall St. Rank hold SCG as of Q4 2015.

  • Aspiriant Holdings S3 held 15,432 shares of Scana worth $933K as of Q4 2015.
  • Aspiriant Holdings S3 bought 312 Scana shares in Q4 2015, an estimated $18.3K.
  • Scana made up 0.4% of Aspiriant Holdings S3's portfolio in Q4 2015, its #70 holding.
  • Aspiriant Holdings S3 first reported a position in Scana in Q3 2013 and has held it in 10 quarters since.
  • Aspiriant Holdings S3's Scana position peaked at $3.52M in Q4 2014.
  • 458 funds tracked by Wall St. Rank held Scana as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.